{"count": 5, "results": [{"_id": "35703816", "pmid": 35703816, "title": "Effect of Metformin on HIF-1alpha Signaling and Postoperative Adhesion Formation.", "journal": "J Am Coll Surg", "authors": ["Biller ML", "Tuffs C", "Bleul M", "Tran DT", "Dupovac M", "Keppler U", "Harnoss JM", "Probst P", "Schneider M", "Strowitzki MJ"], "date": "2022-06-01T00:00:00Z", "doi": "10.1097/XCS.0000000000000205", "meta_date_publication": "2022 Jun 1", "meta_volume": "234", "meta_issue": "6", "meta_pages": "1167-1180", "score": 50258.133, "text_hl": "@SPECIES_10090 @@@Mice@@@ were treated with vehicle or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 3 days before and until 7 days after induction of @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritoneal adhesions@@@; alternatively, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment was discontinued 48 hours before induction of @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritoneal adhesions@@@. ", "citations": {"NLM": "Biller ML, Tuffs C, Bleul M, Tran DT, Dupovac M, Keppler U, Harnoss JM, Probst P, Schneider M, Strowitzki MJ. Effect of Metformin on HIF-1alpha Signaling and Postoperative Adhesion Formation. J Am Coll Surg. 2022 Jun 1;234(6):1167-1180. PMID: 35703816", "BibTeX": "@article{35703816, title={Effect of Metformin on HIF-1alpha Signaling and Postoperative Adhesion Formation.}, author={Biller ML and Tuffs C and Bleul M and Tran DT and Dupovac M and Keppler U and Harnoss JM and Probst P and Schneider M and Strowitzki MJ}, journal={J Am Coll Surg}, volume={234}, number={6}, pages={1167-1180}}"}}, {"_id": "30396946", "pmid": 30396946, "title": "The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.", "journal": "Anticancer Res", "authors": ["Sekino N", "Kano M", "Matsumoto Y", "Sakata H", "Murakami K", "Toyozumi T", "Otsuka R", "Yokoyama M", "Shiraishi T", "Okada K", "Kamata T", "Ryuzaki T", "Matsubara H"], "date": "2018-11-01T00:00:00Z", "doi": "10.21873/anticanres.12982", "meta_date_publication": "2018 Nov", "meta_volume": "38", "meta_issue": "11", "meta_pages": "6263-6269", "score": 50066.098, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ also suppressed @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritoneal metastasis@@@. ", "citations": {"NLM": "Sekino N, Kano M, Matsumoto Y, Sakata H, Murakami K, Toyozumi T, Otsuka R, Yokoyama M, Shiraishi T, Okada K, Kamata T, Ryuzaki T, Matsubara H. The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis. Anticancer Res. 2018 Nov;38(11):6263-6269. PMID: 30396946", "BibTeX": "@article{30396946, title={The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis.}, author={Sekino N and Kano M and Matsumoto Y and Sakata H and Murakami K and Toyozumi T and Otsuka R and Yokoyama M and Shiraishi T and Okada K and Kamata T and Ryuzaki T and Matsubara H}, journal={Anticancer Res}, volume={38}, number={11}, pages={6263-6269}}"}}, {"_id": "31519569", "pmid": 31519569, "title": "Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment.", "journal": "Anticancer Res", "authors": ["Hirayama T", "Nagata Y", "Nishida M", "Matsuo M", "Kobayashi S", "Yoneda A", "Kanetaka K", "Udono H", "Eguchi S"], "date": "2019-09-01T00:00:00Z", "doi": "10.21873/anticanres.13652", "meta_date_publication": "2019 Sep", "meta_volume": "39", "meta_issue": "9", "meta_pages": "4699-4709", "score": 50064.113, "text_hl": "This study addressed the immunological effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritoneal dissemination@@@. ", "citations": {"NLM": "Hirayama T, Nagata Y, Nishida M, Matsuo M, Kobayashi S, Yoneda A, Kanetaka K, Udono H, Eguchi S. Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment. Anticancer Res. 2019 Sep;39(9):4699-4709. PMID: 31519569", "BibTeX": "@article{31519569, title={Metformin Prevents Peritoneal Dissemination via Immune-suppressive Cells in the Tumor Microenvironment.}, author={Hirayama T and Nagata Y and Nishida M and Matsuo M and Kobayashi S and Yoneda A and Kanetaka K and Udono H and Eguchi S}, journal={Anticancer Res}, volume={39}, number={9}, pages={4699-4709}}"}}, {"_id": "31693512", "pmid": 31693512, "title": "The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.", "journal": "Am J Clin Oncol", "authors": ["Seo HS", "Jung YJ", "Kim JH", "Lee HH", "Park CH"], "date": "2019-12-01T00:00:00Z", "doi": "10.1097/COC.0000000000000627", "meta_date_publication": "2019 Dec", "meta_volume": "42", "meta_issue": "12", "meta_pages": "909-917", "score": 50046.97, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use was an independent prognostic factor of overall survival, @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ recurrence, and @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritoneal recurrence@@@. ", "citations": {"NLM": "Seo HS, Jung YJ, Kim JH, Lee HH, Park CH. The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus. Am J Clin Oncol. 2019 Dec;42(12):909-917. PMID: 31693512", "BibTeX": "@article{31693512, title={The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.}, author={Seo HS and Jung YJ and Kim JH and Lee HH and Park CH}, journal={Am J Clin Oncol}, volume={42}, number={12}, pages={909-917}}"}}, {"_id": "24091934", "pmid": 24091934, "title": "Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.", "journal": "Mol Med", "authors": ["Park DW", "Jiang S", "Tadie JM", "Stigler WS", "Gao Y", "Deshane J", "Abraham E", "Zmijewski JW"], "date": "2013-11-08T00:00:00Z", "doi": "10.2119/molmed.2013.00065", "meta_date_publication": "2013 Nov 8", "meta_volume": "19", "meta_issue": "1", "meta_pages": "387-98", "score": 50040.434, "text_hl": "In addition to their effects on chemotaxis, treatment of neutrophils with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_AICA_ribonucleotide @CHEMICAL_MESH:C031143 @@@aminoimidazole carboxamide ribonucleotide@@@ (@CHEMICAL_AICA_ribonucleotide @CHEMICAL_MESH:C031143 @@@AICAR@@@) improved phagocytosis and @DISEASE_Bacterial_Infections @DISEASE_MESH:D001424 @@@bacterial@@@ killing, including more efficient eradication of bacteria in a @SPECIES_10090 @@@mouse@@@ model of @<m>DISEASE_Peritonitis</m> @DISEASE_MESH:D010538 @@@peritonitis@@@-induced @DISEASE_Sepsis @DISEASE_MESH:D018805 @@@sepsis@@@. ", "citations": {"NLM": "Park DW, Jiang S, Tadie JM, Stigler WS, Gao Y, Deshane J, Abraham E, Zmijewski JW. Activation of AMPK enhances neutrophil chemotaxis and bacterial killing. Mol Med. 2013 Nov 8;19(1):387-98. PMID: 24091934", "BibTeX": "@article{24091934, title={Activation of AMPK enhances neutrophil chemotaxis and bacterial killing.}, author={Park DW and Jiang S and Tadie JM and Stigler WS and Gao Y and Deshane J and Abraham E and Zmijewski JW}, journal={Mol Med}, volume={19}, number={1}, pages={387-98}}"}}]}